Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

01477 Ocumension Therapeutics-B

9.380
-0.120-1.26%
Market Close 09/28 16:08 CCT
High
9.600
Open
9.450
Turnover
2.64M
Low
9.290
Pre Close
9.500
Volume
281.50K
Market Cap
6.30B
P/E(TTM)
Loss
52wk High
19.380
Shares
671.94M
P/E(Static)
Loss
52wk Low
7.970
Float Cap
6.30B
Bid/Ask %
-62.16%
Historical High
43.000
Shs Float
671.94M
Volume Ratio
1.17
Historical Low
7.970
Dividend TTM
--
Div Yield TTM
--
P/B
1.83
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.04%
Amplitude
3.26%
Avg Price
9.391
Lot Size
500
Float Cap
6.30B
Bid/Ask %
-62.16%
Historical High
43.000
Shs Float
671.94M
Volume Ratio
1.17
Historical Low
7.970
Dividend TTM
--
P/B
1.83
Dividend LFY
--
Turnover Ratio
0.04%
Amplitude
3.26%
Avg Price
9.391
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Oukangwei Biology is a Chinese holding company mainly engaged in the discovery, development and commercialization of ophthalmic therapy. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202 and so on. The company operates in China.
CEO: Lian Yong CHEN
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...